Evidence map›Paper›PMID 42077462›Full record

ArticleFrontiers in endocrinology2026

Tumor induced-osteomalacia caused by a phosphaturic mesenchymal tumor in the sartorius muscle: a case report.

Weronika Rymon Lipinska, Natalia Filckowska, Marcin Ekman, Jarosław Kobiela

Abstract readCase Reports
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Weronika Rymon LipinskaFaculty of Medicine, Medical University of Gdansk, Gdansk, Poland.
Natalia FilckowskaFaculty of Medicine, Medical University of Gdansk, Gdansk, Poland.
Marcin EkmanDepartment of Surgical Oncology, Transplant Surgery and General Surgery, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland.
Jarosław KobielaDepartment of Surgical Oncology, Transplant Surgery and General Surgery, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome resulting from excessive secretion of fibroblast growth factor-23 (FGF23) by phosphaturic mesenchymal tumors (PMTs). We report the case of a 35-year-old man with a three-year history of progressive musculoskeletal symptoms and severe mobility impairment, who had not received a correct diagnosis during this period. Laboratory evaluation revealed severe hypophosphatemia and elevated FGF23 levels. Magnetic resonance imaging (MRI) and

Indexed as

HypophosphatemiaMesenchymomaNeoplasms, Connective TissueOsteomalaciaParaneoplastic SyndromesAdultFibroblast Growth Factor-23Fibroblast Growth FactorsHumansMagnetic Resonance ImagingMaleFGF23 protein, humanFibroblast Growth Factor-23Fibroblast Growth Factorshypophosphatemiaphosphaturic mesenchymal tumorsoft tissue tumortumor-induced osteomalaciatumor resection

Identifiers

PMID42077462
PMCPMC13132686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.